Beyond the Patent Cliff: Why Pharma’s Layoffs Signal a Deeper Strategic Shift
Large pharmaceutical companies cut more than 22,000 jobs in 2025 as a $300 billion patent cliff approaches, signaling a broad industry correction in workforce size and cost structure ahead of significant revenue losses. These layoffs are not simply cost containment. They reflect deeper strategic recalibration, and companies must respond with…